Retrovirus Construct ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 285 | Fanconi anemia | 1 |
285. Fanconi anemia
Clinical trials : 62 / Drugs : 93 - (DrugBank : 30) / Drug target genes : 30 - Drug target pathways : 144
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00272857 (ClinicalTrials.gov) | August 2004 | 4/1/2006 | Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia | Gene Transfer From Patients With Fanconi Anemia, Genotype A: A Pilot Study | Fanconi Anemia | Genetic: Retrovirus Construct | Boston Children’s Hospital | National Heart, Lung, and Blood Institute (NHLBI);Children's Hospital Medical Center, Cincinnati | Completed | 1 Year | 35 Years | All | 3 | Phase 1 | United States |